[1] 吕文才,邹 运,温 爽,等.中国胆囊癌发病率及流行趋势分析[J].中华消化外科杂志,2019,18(2):186-189.
[2] 孙艳军,孙登群,龚仁华,等.原发性胆囊癌72例[J].武警医学,2013,24(7):623-625.
[3] Kanthan R,Senger J L,Ahmed S,et al.Gallbladder cancer in the 21st century[J].J Oncol,2015,2015:967472.
[4] Amin M B,Greene F L,Edge S B,et al.The eighth edition AJCC cancer staging manual:continuing to build a bridge from a population-based to a more "personalized"approach to cancer staging[J].CA Cancer J Clin,2017,67(2):93-99.
[5] Chun Y S,Pawlik T M,Vauthey J N.8th edition of the AJCC cancer staging manual:pancreas and hepatobiliary cancers[J].Ann Surg Oncol,2018,25(4):845-847.
[6] Shindoh J,de Aretxabala X,Aloia T A,et al.Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer:an international multicenter study[J].Ann Surg,2015,261(4):733-739.
[7] Lee W,Jeong C Y,Jang J Y,et al.Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study[J].Surgery,2017,162(3):515-524.
[8] Kim S H,Chong J U,Lim J H,et al.Optimal assessment of lymph node status in gallbladder cancer[J].Eur J Surg Oncol,2016,42(2):205-210.
[9] 耿智敏,汤朝晖.2018年NCCN指南更新版胆囊癌诊治进展述评[J].西部医学,2018,30(7):937-942,947.
[10] 中国抗癌协会.胆囊癌规范化诊治专家共识(2016)[J].中华肝胆外科杂志,2016,22(11):721-728.
[11] 梁廷波.从NCCN指南看胆囊癌的规范化综合治疗[J].中国实用外科杂志,2016,36(10):1025-1028.
[12] Alshari O M,Dawaymeh T A,Tashtush N A,et al.Completely resolved advanced biliary tract cancer after treatment by pembrolizumab:a report of two cases[J].Onco Targets Ther,2019,12:5293-5298.
[13] Cha S Y,Kim Y K,Min J H,et al.Usefulness of noncontrast MRI in differentiation between gallbladder carcinoma and benign conditions manifesting as focal mild wall thickening[J].Clin Imaging,2019,54:63-70.
[14] Kim S J,Lee J M,Lee E S,et al.Preoperative staging of gallbladder carcinoma using biliary MR imaging[J].J Magn Reson Imaging,2015,41(2):314-321.
[15] Yoshimitsu K,Nishihara Y,Okamoto D,et al.Magnetic resonance differentiation between T2 and T1 gallbladder carcinoma:significance of subserosal enhancement on the delayed phase dynamic study[J].Magn Reson Imaging,2012,30(6):854-859.
[16] Arslan E,Aksoy T,Dursun N,et al.The role of 18F-FDG PET/CT in staging of gallbladder carcinomas[J].Turk J Gastroenterol,2020,31(2):105-112.
[17] Nanashima A,Sakamoto I,Hayashi T,et al.Preoperative diagnosis of lymph node metastasis in biliary and pancreatic carcinomas:evaluation of the combination of multi-detector CT and serum CA19-9 level[J].Dig Dis Sci,2010,55(12):3617-3626.
[18] 邱智泉,于 勇,罗祥基,等.胆囊癌与黄色肉芽肿性胆囊炎的鉴别诊断及手术治疗策略[J].中华肝胆外科杂志,2017,23(5):336-338.
[19] 王建良,朱玉春,邢 伟,等.黄色肉芽肿性胆囊炎与厚壁型胆囊癌的螺旋CT鉴别诊断[J].临床放射学杂志,2015,34(1):74-78.
[20] Clemente G,Tringali A,De Rose A M,et al.Mirizzi syndrome:diagnosis and management of a challenging biliary disease[J].Can J Gastroenterol Hepatol,2018,2018:6962090.